Document:

Assumption Agreement

 Exhibit 10.6 

 

			
	 	  	
	 	  	
	 	  	
	 After recording, return to:
	  	
	 	
	 Bilzin Sumberg Baena
	  	
	 Price & Axelrod LLP
	  	
	 200 South Biscayne Boulevard, Suite 2500
	  	
	 Miami, Florida 33131-5340
	  	
	 Attn: Post-Closing Department
	  	

  
  

(Space Above For Recorder’s Use Only)             

NOTE AND DEED OF TRUST 
 ASSUMPTION AGREEMENT 
 (JPMCC 2006-LDP6; Loan No. 030256201)

 THIS NOTE AND DEED OF TRUST ASSUMPTION AGREEMENT (“Agreement”) is executed
May 10, 2011, effective as of May 13, 2011, and is entered into among WELLS FARGO BANK, N.A., A NATIONAL BANKING ASSOCIATION, AS TRUSTEE FOR THE REGISTERED HOLDERS OF J.P. MORGAN CHASE COMMERCIAL MORTGAGE SECURITIES CORP., COMMERCIAL
MORTGAGE PASS-THROUGH CERTIFICATES, SERIES 2006-LDP6 (“Lender”), each having an address at 9062 Old Annapolis Road, Columbia, MD 21045, Attention: Corporate Trust Services CMBS, Re: JPMCC 2006-LDP6; Loan No 030256201; GRIFFIN
CAPITAL (CARLSBAD POINTE) INVESTORS, LLC (“Griffin Capital”), GRIFFIN CAPITAL (CARLSBAD POINTE) INVESTOR 1, LLC (“TIC 1”), GRIFFIN CAPITAL (CARLSBAD POINTE) INVESTOR 2, LLC (“TIC 2”), GRIFFIN CAPITAL (CARLSBAD POINTE)
INVESTOR 3, LLC (“TIC 3”), GRIFFIN CAPITAL (CARLSBAD POINTE) INVESTOR 4, LLC (“TIC 4”), GRIFFIN CAPITAL (CARLSBAD POINTE) INVESTOR 5, LLC (“TIC 5”), GRIFFIN CAPITAL (CARLSBAD POINTE) INVESTOR 6, LLC (“TIC 6”),
GRIFFIN CAPITAL (CARLSBAD POINTE) INVESTOR 7, LLC (“TIC 7”), GRIFFIN CAPITAL (CARLSBAD POINTE) INVESTOR 8, LLC (“TIC 8”), GRIFFIN CAPITAL (CARLSBAD POINTE) INVESTOR 9, LLC (“TIC 9”), GRIFFIN CAPITAL (CARLSBAD POINTE)
INVESTOR 10, LLC (“TIC 10”), GRIFFIN CAPITAL (CARLSBAD POINTE) INVESTOR 11, LLC (“TIC 11”), GRIFFIN CAPITAL (CARLSBAD POINTE) INVESTOR 12, LLC (“TIC 12”), GRIFFIN CAPITAL (CARLSBAD POINTE) INVESTOR 13, LLC (“TIC
13”), GRIFFIN CAPITAL (CARLSBAD POINTE) INVESTOR 14, LLC (“TIC 14”), GRIFFIN CAPITAL (CARLSBAD POINTE) INVESTOR 15, LLC (“TIC 15”), GRIFFIN CAPITAL (CARLSBAD POINTE) INVESTOR 16, LLC (“TIC 16”), GRIFFIN CAPITAL
(CARLSBAD POINTE) INVESTOR 17, LLC (“TIC 17”), GRIFFIN CAPITAL (CARLSBAD POINTE) INVESTOR 18, LLC (“TIC 18”), GRIFFIN CAPITAL (CARLSBAD POINTE) INVESTOR 19, LLC (“TIC 19”), GRIFFIN CAPITAL (CARLSBAD POINTE) INVESTOR 20,
LLC (“TIC 20”), GRIFFIN CAPITAL (CARLSBAD POINTE) INVESTOR 21, LLC (“TIC 21”), GRIFFIN CAPITAL  

 
(CARLSBAD POINTE) INVESTOR 22, LLC (“TIC 22”), GRIFFIN CAPITAL (CARLSBAD POINTE) INVESTOR 23, LLC (“TIC 23”), GRIFFIN CAPITAL (CARLSBAD POINTE) INVESTOR 24, LLC (“TIC
24”), GRIFFIN CAPITAL (CARLSBAD POINTE) INVESTOR 25, LLC (“TIC 25”), GRIFFIN CAPITAL (CARLSBAD POINTE) INVESTOR 26, LLC (“TIC 26”), GRIFFIN CAPITAL (CARLSBAD POINTE) INVESTOR 27, LLC (“TIC 27”), GRIFFIN CAPITAL
(CARLSBAD POINTE) INVESTOR 28, LLC (“TIC 28”), GRIFFIN CAPITAL (CARLSBAD POINTE) INVESTOR 29, LLC (“TIC 29”), each a Delaware limited liability company (collectively, “Original Borrower”), each having an
address at c/o Griffin Capital, 2121 Rosecrans Avenue, Suite 3321, El Segundo, California 90245 and THE GC NET LEASE (CARLSBAD) INVESTORS, LLC, a Delaware limited liability company (“New Borrower”), having an
address at C/O Griffin Capital, 2121 Rosecrans Avenue, Suite 3321, El Segundo , California 90245. Original Borrower and New Borrower are hereinafter sometimes collectively referred to as “Borrower Parties”. 

PRELIMINARY STATEMENT 
 A.        Original Borrower is the current owner of fee title to that certain real property (“Land”) and the buildings and improvements
thereon (“Improvements”), commonly known as “5781 Van Allen Way,” Carlsbad, California, more particularly described in Exhibit A attached hereto and made a part hereof (the Land and the Improvements are
hereinafter sometimes collectively referred to as the “Project”). 

B.        Lender is the current owner and holder of a loan
(“Loan”) in the original principal amount of $37,000,000.00, as evidenced and/or secured by the documents described on Exhibit B attached hereto (together with any and all other agreements, documents, instruments
evidencing, securing or in any manner relating to the Loan, as all of the same may be amended, restated, supplemented or otherwise modified from time to time, shall hereinafter be collectively referred to as the “Loan Documents”).
The Loan is secured in part by the Project, which Project is described in and encumbered by the “Security Instrument” described on Exhibit B. 

C.        New Borrower desires to purchase the Project from Original Borrower and
to assume Original Borrower’s obligations under the Loan Documents as provided herein. 

D.        A sale of the Project to, and the assumption of the Loan by, a third
party without the consent of the holder of the Security Instrument is prohibited by the terms thereof. 

E.        The Lender has agreed to consent to the following requested actions
(collectively the “Requested Actions”): (i) Original Borrower selling the Project to New Borrower, (ii) New Borrower assuming all of Original Borrower’s obligations under the Loan Documents, on the terms and
conditions hereinafter set forth. 
 In consideration of $10.00 paid by each of the parties to the other, the
mutual covenants set forth below, and other good and valuable consideration, receipt and sufficiency of which are acknowledged, the parties agree as follows: 

  
 2 

 ARTICLE 1 
 ACKNOWLEDGMENTS, WARRANTIES AND REPRESENTATIONS 

1.1        Original Borrower Representations. As a material
inducement to Lender to enter into this Agreement and to consent to the Requested Actions, Original Borrower acknowledges, warrants, represents and agrees to and with Lender as follows: 

(a)        Incorporation of Recitals. All of the facts set forth in the
Preliminary Statement of this Agreement are true and correct and incorporated into this Agreement by reference. 
 (b)        Authority of Original Borrower. Each Original Borrower is a duly organized, validly existing limited liability company in good standing under the
laws of the State of Delaware and is qualified to transact business in the State of California. By his/her or their execution of this Agreement, the individual(s) signing this Agreement on behalf of an Original Borrower or on behalf of any
entit(ies) signing on behalf of an Original Borrower represent and warrant to Lender, that each such individual(s), acting alone without the joinder of any other party, has the power and authority to execute this Agreement on behalf of and to duly
bind such Original Borrower, or in the case of an entity signing on behalf an Original Borrower, duly bind such entit(ies) and such Original Borrower under this Agreement. The execution and delivery of, and performance under, this Agreement by each
Original Borrower have been duly and properly authorized pursuant to all requisite limited liability company action and will not (i) violate any provision of any law, rule, regulation, order, writ, judgment, injunction, decree, determination or
award presently in effect having applicability to Original Borrower or the articles of organization, certificate of formation, operating agreement, limited liability company agreement or any other organizational document of Original Borrower or
(ii) result in a breach of or constitute or cause a default under any indenture, agreement, lease or instrument to which Original Borrower is a party or by which the Project may be bound or affected. 

(c)        Tenant in Common Agreement and Related Documents. Each
Original Borrower hereby consents to the transfer and conveyance of the undivided interest of the other Original Borrowers in the Project to New Borrower, and waives any rights under that certain Tenants in Common Agreement dated February 12,
2006, and related documents, including without limitation, the Call Agreement, entered into in connection therewith or in connection with any of the transactions contemplated by this Agreement, including, without limitation, any restrictions on
transfer, buy/sell rights, rights of appraisal, piggyback rights or rights of first offer or first refusal and any notice requirements in connection therewith or otherwise. 

(d)        Compliance with Laws. To Original Borrower’s knowledge,
all permits, licenses, franchises or other evidences of authority to use and operate the Project as it is presently being operated and as contemplated by the Loan Documents are current, valid and in full force and effect. Original Borrower has not
received any written notice from any governmental entity claiming that Original Borrower or the Project is not presently in compliance with any laws, ordinances, rules and regulations bearing upon the use and operation of the Project, including,
without limitation, any notice relating to any violations of zoning, building, environmental, fire, health, or other laws, ordinances, rules, codes or regulations. 

  
 3 

 (e)        LTC Lease. The
LTC Lease dated February 8, 2006, between Original Borrower, as Landlord, and Invitrogen Corporation, as Tenant, predecessor to Life Technologies Corporation, f/k/a Applied Biosystems, a Delaware corporation, the current Tenant under the LTC
Lease, as modified by amendments dated January 29, 2008, August 26, 2009, January 28, 2010, and July 7, 2010 (as amended, the “LTC Lease”) is the only lease affecting the Project and is currently in
full force and effect; Borrower has not been notified of any landlord default under the LTC Lease; there are no leasing broker’s or finder’s commissions of any kind due or to become due with respect to the LTC Lease or the Project and no
security deposit has been paid under the LTC Lease. No material default currently exists or with the passage of time, the giving of notice, or both, is due to exist under the LTC Lease. There is no requirement under the LTC Lease to obtain the
Tenant’s consent to the Requested Actions. 
 (f)        Title
to Project and Legal Proceedings. Original Borrower is the current owner of fee title in the Project. There are no pending or, to the best of knowledge of Original Borrower, threatened suits, judgments, arbitration proceedings, administrative
claims, executions or other legal or equitable actions or proceedings against Original Borrower or the Project, or any pending or, to the best of knowledge of Original Borrower, threatened condemnation proceedings or annexation proceedings affecting
the Project, or any agreements to convey any portion of the Project, or any rights thereto to any person, entity, or government body or agency not disclosed in this Agreement. 

(g)        Loan Documents. The Loan Documents constitute valid and
legally binding obligations of Original Borrower enforceable against Original Borrower, as limited herein, and the Project in accordance with their terms. Original Borrower acknowledges and agrees that nothing contained in this Agreement, nor the
Requested Actions, shall release or relieve Original Borrower from its obligations, agreements, duties, liabilities, covenants and undertakings under the Loan Documents arising prior to the date hereof. Original Borrower has no defenses, setoffs,
claims, counterclaims or causes of action of any kind or nature whatsoever against Lender or any of Lender’s predecessors in interest, and any subsidiary or affiliate of Lender and all of the past, present and future officers, directors,
contractors, employees, agents, servicers (including, but not limited to, Midland Loan Services, Inc. and LNR Partners, LLC, successor by statutory conversion to LNR Partners, Inc.), attorneys, representatives, participants, successors and assigns
of Lender and Lender’s predecessors in interest (collectively, “Lender Parties”) or with respect to (i) the Debt (as such term is defined in the Security Instrument), (ii) the Loan Documents, or (iii) the
Project. To the extent Original Borrower would be deemed to have any such defenses, setoffs, claims, counterclaims or causes of action as of the date hereof, Original Borrower knowingly waives and relinquishes them. 

(h)        Bankruptcy. Original Borrower has no intent to (i) file
any voluntary petition under any Chapter of the Bankruptcy Code, Title 11, U.S.C.A. (“Bankruptcy Code”), or in any manner to seek any proceeding for relief, protection, reorganization, liquidation, dissolution or similar relief for
debtors (“Debtor Proceeding”) under any local, state, federal or other insolvency law or laws providing relief for debtors, (ii) directly or indirectly cause any involuntary petition under any Chapter of the Bankruptcy Code to
be filed against Original Borrower or any members thereof or (iii) directly or indirectly cause the Project or any portion or any interest of Original Borrower in the Project to become the property of any bankrupt estate or the subject of any
Debtor Proceeding. 

  
 4 

 (i)        No Default. To
Original Borrower’s knowledge, no event, fact or circumstance has occurred or failed to occur which constitutes, or with the lapse or passage of time, giving of notice or both, could constitute a default or Event of Default under the Loan
Documents. 
 (j)        Reaffirmation. Original Borrower
reaffirms and confirms the truth and accuracy of all representations and warranties set forth in the Loan Documents, in all material respects, as if made on the date hereof. 

1.2        Acknowledgments, Warranties and Representations of New
Borrower. As a material inducement to Lender to enter into this Agreement and to consent to the Requested Actions, New Borrower acknowledges, warrants, represents and agrees to and with Lender as follows: 

(a)        Incorporation of Recitals. All of the facts set forth in the
Preliminary Statement of this Agreement are true and correct and incorporated into this Agreement by reference. 
 (b)        Authority of New Borrower. 
 (i)        New Borrower. New Borrower is a duly organized, validly existing limited liability company in good standing under the laws of the State of
Delaware and is qualified to transact business in the State of California. The GC Net Lease Operating Partnership, L.P. (the “Operating Partnership”) is the sole member of New Borrower. Operating Partnership, acting alone without
the joinder of any manager of New Borrower or any other party, has the power and authority to execute this Agreement on behalf of and to duly bind New Borrower under this Agreement and the Loan Documents. The execution and delivery of, and
performance under, this Agreement and the Loan Documents by New Borrower have been duly and properly authorized pursuant to all requisite company action and will not (i) violate any provision of any law, rule, regulation, order, writ, judgment,
injunction, decree, determination or award presently in effect having applicability to New Borrower or the articles of organization, certificate of formation, operating agreement, limited liability company agreement, or any other organizational
document of New Borrower or (ii) result in a breach of or constitute or cause a default under any indenture, agreement, lease or instrument to which New Borrower is a party or by which the Project may be bound or affected. 

(ii)        Operating Partnership. Operating Partnership is a duly
organized, validly existing limited partnership in good standing under the laws of the State of Delaware and is qualified to transact business in the State of California. The GC Net Lease REIT, Inc. (the “REIT”) is the sole general
partner of the Operating Partnership. The REIT, acting alone without the joinder of any other partner of the Operating Partnership or any other party, has the power and authority to execute this Agreement on behalf of and to duly bind the Operating
Partnership and New Borrower under this Agreement and the Loan Documents. The execution and delivery of, and performance under, this Agreement and the Loan Documents by the Operating Partnership have been duly and properly authorized pursuant to all
requisite partnership action and will not (i) violate any provision of any law, rule, regulation, order, writ, judgment, injunction, decree, determination or award presently in effect having applicability to

  
 5 

 
the Operating Partnership or the certificate of limited partnership or limited partnership agreement or any other organizational document of the Operating Partnership or (ii) result in a
breach of or constitute or cause a default under any indenture, agreement, lease or instrument to which the Operating Partnership is a party or by which the Project may be bound or affected. 

(iii)        REIT. The REIT is a duly organized, validly existing
corporation in good standing under the laws of the State of Maryland and is qualified to conduct business in California. Any of Kevin Shields, Julie Treinen, Michael Escalante, Joseph Miller or Mary Higgins (each an “Authorized
Officer”), as Authorized Officers of the REIT, acting alone without the joinder of any other officer or director of the REIT or any other party, has the power and authority to execute this Agreement on behalf of and to duly bind the REIT,
the Operating Partnership and New Borrower under this Agreement and the Loan Documents. The execution and delivery of, and performance under, this Agreement and the Loan Documents by Authorized Officer on behalf of the REIT have been duly and
properly authorized pursuant to all requisite corporate action and will not (i) violate any provision of any law, rule, regulation, order, writ, judgment, injunction, decree, determination or award presently in effect having applicability to
the REIT or the articles of incorporation or bylaws or any other organizational document of the REIT or (ii) result in a breach of or constitute or cause a default under any indenture, agreement, lease or instrument to which the REIT is a party
or by which the Project may be bound or affected. 

(c)        Financial Statements. The financial statements and other
information (“Financial Statements”) of the Operating Partnership and the REIT (individually and/or collectively “Principal”) which have been previously delivered to Lender are true, complete and accurate in all
material respects and accurately represent the financial condition of Principal as of the date thereof. All of the assets shown on each Principal’s Financial Statements are owned by such Principal, individually, as their sole and separate
property, and not otherwise jointly with any other person or entity. There has not been any material adverse change to the financial condition of Principal between the dates of the Financial Statements and the date of this Agreement. New Borrower
also acknowledges and agrees to cause Principal to timely comply with all financial, bookkeeping and reporting requirements set forth in the Loan Documents, including, without limitation, those set forth in Section 3.8 of the Security
Instrument. New Borrower acknowledges that the Financial Statements have been provided to Lender in conjunction with the assumption by Principal of the obligations of Current Sponsor Guarantor under the Guaranty, as described in Section 4.12
herein, and are being relied upon by Lender solely for such purpose. Lender agrees that since New Borrower is a single member limited liability company, to the extent that the Operating Partnership files a tax return instead of New Borrower, that it
will provide Lender with the tax returns for the Operating Partnership instead of New Borrower. Similarly, to the extent that the balance sheets and financial statement of New Borrower are consolidated with this of the Operating Partnership, that
the consolidated balance sheets and financial statements will clearly identify the assets and liabilities of New Borrower as belonging to New Borrower and will provide Lender with copies of said consolidated balance sheets and financial statements.

 (d)        Bankruptcy Proceedings. None of New Borrower, the
Operating Partnership nor the REIT or other entities which may be owned or controlled directly or indirectly by New Borrower, the Operating Partnership or the REIT (collectively, “Related

  
 6 

 
Entities”) has been a party to any Debtor Proceeding within seven (7) years prior to the date of this Agreement. 

(e)        Defaults on Other Indebtedness. Neither New Borrower nor any
Related Entities has materially defaulted under its or their obligations with respect to any other indebtedness. 
 (f)        New Borrower’s Organizational Documents. New Borrower has not transacted any business in New Borrower’s name since its formation. New
Borrower is and will continue to be in full compliance with all of its organizational documents and the single purpose entity and separateness requirements of the Loan Documents and such organizational documents do not conflict with any of such
single purpose entity and separateness requirements of the Loan Documents. 

(g)        Assets of New Borrower. The only assets of New Borrower are
the Project, the personal property owned by New Borrower and used in connection with the Project and cash or cash equivalents. 
 (h)        Management of Project. New Borrower is entering into that certain Property Management and Leasing Agreement with The GC Net Lease REIT Property
Management, LLC, a Delaware limited liability company (“Project Manager”) for the management of the Project (the “New Management Agreement”). The term “Management Agreement” or “management
agreement” or such other similar term in the Loan Documents shall hereafter refer to the New Management Agreement. The term “Property Manager” or such other similar term in the Loan Documents shall hereafter refer to the
Project Manager. New Borrower covenants and agrees to comply with and to cause the Project Manager to comply with all terms and conditions of the Loan Documents concerning the management of the Project, including without limitation the obligation to
obtain Lender’s consent to change the management of the Project to an entity or person other than Project Manager or to any transfer which would result in Kevin Shields (“Shields”) owning less than 51% of the direct or indirect
ownership interests in Project Manager. Project Manager shall execute and deliver to Lender a subordination of the New Management Agreement in form acceptable to Lender. 

(i)        Loans to Related Entities. There are no loans payable by New
Borrower to any member(s) of New Borrower or any other Related Entities or other entities or persons. 

(j)        Non-Consolidation Opinion. New Borrower will comply with each
of the assumptions made with respect to it in that certain substantive non-consolidation opinion letter, dated the date hereof, delivered by New Borrower’s counsel in connection with the Requested Actions (the “Non-Consolidation
Opinion”), including but not limited to, any exhibits attached hereto, any certificates referred to therein and any subsequent non-consolidation opinion delivered in accordance with the terms and conditions of the Security Instrument. New
Borrower has caused and shall cause each entity other than the New Borrower with respect to which an assumption is made in the Non-Consolidation Opinion, including but not limited to, any exhibits attached thereto, and to comply with each of the
assumptions made with respect to it in the Non-Consolidation Opinion, including, but not limited to, any exhibits attached thereto, and any certificates referred to therein. All of the assumptions made in the Non-Consolidation

  
 7 

 
Opinion, including, but not limited to, any exhibits attached thereto, and any certificates referred to therein are true and correct. 

(k)        New Borrower Parties’ Interests. Neither New Borrower nor
any of its members or managers is obtaining a loan to finance its interest in New Borrower or the Project, other than that certain bridge loan in an amount not to exceed $12,300,000.00 made to the Operating Partnership, which bridge loan is not
secured by a pledge of any direct or indirect ownership interest in New Borrower or the Project. 

(l)        Prohibited Person. New Borrower warrants and represents, after
review of the website identified below, that neither New Borrower nor Principal nor any of their respective officers, directors, shareholders, partners, members or affiliates (including the holders of indirect equity interests in New Borrower) is an
entity or person (i) that is listed in the Annex to, or is otherwise subject to the provisions of, Executive Order 13224, issued on September 24, 2001 (“EO13224”), (ii) whose name appears on the United States Treasury
Department’s Office of Foreign Assets Control (“OFAC”) most current list of “Specifically Designated Nationals and Blocked Persons” (which list may be published from time to time in various media including but
not limited to, the OFAC website, http://www.treas.gov/offices/enforcement/ofac/sdn/t11sdn.pdf, (iii) who commits, threatens to commit or supports “terrorism”, as that term is defined in EO13224, or (iv) who, to the
knowledge of New Borrower, is otherwise affiliated with any entity or person listed above (any and all parties or persons described in clauses [i] – [iv] above are herein referred to as a “Prohibited Person”). New
Borrower covenants and agrees that neither New Borrower nor Principal nor any of their respective officers, directors, shareholders, partners, members or affiliates (including the holders of indirect equity interests in New Borrower) will
(a) knowingly conduct any business, or engage in any transaction or dealing, with any Prohibited Person, including, but not limited to, the making or receiving of any contribution of funds, goods, or services, to or for the benefit of a
Prohibited Person, or (b) knowingly engage in or conspire to engage in any transaction that evades or avoids, or has the purpose of evading or avoiding, or attempts to violate, any of the prohibitions set forth in EO13224. New Borrower further
covenants and agrees to deliver (from time to time) to Lender any such certification as may be requested by Lender in its reasonable discretion, confirming that, based on reasonable inquiry (x) neither New Borrower nor Principal nor any of
their respective officers, directors, shareholders, partners, members or affiliates (including the holders of indirect equity interests in New Borrower) is a Prohibited Person and (y) neither New Borrower, Principal nor their respective
officers, directors, shareholders, partners, members or affiliates (including the holders of indirect equity interests in New Borrower) has (a) knowingly conducted any business, or engaged in any transaction or dealing, with any Prohibited
Person, including, but not limited to, the making or receiving of any contribution of funds, goods, or services, to or for the benefit of a Prohibited Person or (b) knowingly engaged in or conspired to engage in any transaction that evaded or
avoided, or had the purpose of evading or avoiding, or attempted to violate, any of the prohibitions set forth in EO13224. 
 (m)        Loan Documents. The Loan Documents, from and after the date hereof, are valid and legally binding obligations of New Borrower, enforceable against
New Borrower and the Project in accordance with their terms. This Agreement and the execution of other documents contemplated hereby do not constitute the creation of a new debt or the extinguishment of the debt evidenced by the Loan Documents, nor
will they in any way affect or 

  
 8 

 
impair the liens and security interests created by the Loan Documents, which New Borrower acknowledges to be valid and existing liens and security interests in the Project. New Borrower agrees
that the lien and security interests created by the Loan Documents continue to be in full force and effect, unaffected and unimpaired by this Agreement or by the transfer of the Project or any collateral described in financing statements filed in
connection with the Loan Documents and that said liens and security interests shall so continue in their perfection and priority until the debt secured by the Loan Documents is fully discharged. New Borrower has no defenses, affirmative defenses,
setoffs, claims, counterclaims, crossclaims or causes of action of any kind or nature whatsoever against the Lender Parties with respect to (i) the Loan, (ii) the Loan Documents, or (iii) the Project. To the extent New Borrower would
be deemed to have any such defenses, affirmative defenses, setoffs, claims, counterclaims, crossclaims or causes of action as of the date hereof, New Borrower knowingly waives and relinquishes them. New Borrower acknowledges that it has received
copies of all of the Loan Documents. 
 (n)        No Default.
To New Borrower’s actual knowledge, no event, fact or circumstance has occurred or failed to occur which constitutes, or with the lapse or passage of time, giving of notice or both, could constitute a default or Event of Default under the Loan
Documents. 
 (o)        Inspections. New Borrower has not
obtained any written inspection reports relating to the condition of the Project. 

(p)        Reaffirmation. To New Borrower’s actual knowledge,
New Borrower affirms and confirms the truth and accuracy of all representations and warranties set forth in the Loan Documents, in all material respects, as if made on the date hereof. 

(q)        Acknowledgment of Waiver of Right to Prepay Loan. BY
INITIALING BELOW, NEW BORROWER HEREBY EXPRESSLY ACKNOWLEDGES AND UNDERSTANDS THAT NEW BORROWER HAS NO RIGHT TO PREPAY THE NOTE IN WHOLE OR IN PART WITHOUT PAYMENT OF THE PREPAYMENT PREMIUM DESCRIBED IN AND PURSUANT TO THE TERMS OF
PARAGRAPH 7 OF THE NOTE, AND THAT NEW BORROWER SHALL BE LIABLE FOR THE PAYMENT OF SAID PREPAYMENT PREMIUM PURSUANT TO THE TERMS OF PARAGRAPH 7 OF THE NOTE, IF AND TO THE EXTENT APPLICABLE UNDER PARAGRAPH 7. BY INITIALING BELOW, NEW
BORROWER HEREBY AGREES TO THE TERMS OF PARAGRAPH 7 OF THE NOTE, INCLUDING, BUT NOT LIMITED TO THE WAIVERS SET FORTH THEREIN, AND EXPRESSLY ACKNOWLEDGES AND UNDERSTANDS THAT LENDER HAS CONSENTED TO THE REQUESTED ACTIONS IN RELIANCE UPON SAID
AGREEMENTS AND WAIVER OF NEW BORROWER AND THAT LENDER WOULD NOT HAVE CONSENTED TO THE REQUESTED ACTIONS WITHOUT SUCH AGREEMENTS AND WAIVERS OF NEW BORROWER. 
  

					
		 	X	  	
		 	New Borrower’s Initials	  	

  
 9 

 ARTICLE 2 
 ACKNOWLEDGMENTS AND COVENANTS OF BORROWER PARTIES 
 As a
material inducement to Lender to enter into this Agreement and to consent to Requested Actions each of Borrower Parties, as to itself only, acknowledges, warrants, represents, covenants and agrees to and with Lender as follows: 

2.1        Amended and Restated Reciprocal Parking, Access and Easement
Agreement. Borrower Parties acknowledge and agree that all of Original Borrower’s rights under that certain Amended and Restated Reciprocal Parking, Access and Easement Agreement (the “REA”) dated as of
September 20, 2010, among Original Borrower, as the Griffin Group, LTC, as LIFE, and Mararisk Carlsbad, LLC, as Mararisk, recorded on September 21, 2010 as Document No. 2010-0499652 in the San Diego County Recorder’s Office and
any and all of the documents described therein have been irrevocably, unconditionally and absolutely granted, bargained, sold, enfeoffed, assigned, warranted, transferred and conveyed to Lender pursuant to the terms of the Security Instrument and
such rights under the REA constitute a portion of the Property securing the Debt and assigned to New Borrower. 

2.2        Assumption of Loan. New Borrower hereby assumes the
indebtedness due under the Note, the Loan and all of Original Borrower’s other obligations, as grantor, mortgagor, borrower, assignor, trustor, indemnitor, guarantor, or maker, as the case may be, under the Loan Documents to the same extent as
if New Borrower had signed such instruments. New Borrower agrees to comply with and be bound by all the terms, covenants and agreements, conditions and provisions set forth in the Loan Documents. 

2.3        Indebtedness. As of the date hereof, the outstanding
principal balance of the Loan is $34,425448.60. In the event of any error in, or omission from, the foregoing, Lender shall not be prejudiced, limited, or estopped, in any way in its right to charge, collect and receive any and all monies lawfully
due Lender under the Loan Documents. By its execution hereof, Lender represents and warrants to New Borrower that to Lender’s actual knowledge (i) the amounts set forth above are correct, (ii) Lender has not issued any written notices
of default to Original Borrower which have not been cured, and (iii) there are no existing material defaults under the Loan Documents. 
 2.4        Assumption Fee. Simultaneously with or prior to the execution hereof, any or both of Borrower Parties shall pay to or has paid Lender:
(i) an application fee of $10,000.00; (ii) an assumption fee equal to $344,254.49, which is 1% of the outstanding principal balance of the Loan; (iii) an administration fee equal to $125.00; (iv) a flood determination fee
equal to $15.00; (v) a credit review fee equal to $976.50; and (iv) an insurance review fee equal to $400.00, each of which Borrower Parties agrees are fees for new consideration and are not interest charged in connection with the Loan.

 2.5        Payment of Transaction Costs and Expenses.
Any or both of Borrower Parties shall pay at the time of execution of this Agreement by Lender: (a) the legal fees and disbursements of Lender’s counsel, Bilzin Sumberg Baena Price & Axelrod LLP, in connection with the preparation
of this Agreement and the transactions contemplated in this Agreement; (b)

  
 10 

 
all recording costs and documentary stamps, or other taxes if any, due upon the recording of this Agreement; and (c) the costs of updating Lender’s policy of title insurance insuring
the Security Instrument to a current date and endorsing such policy to include this Agreement in the description of the Security Instrument with no additional exceptions, or, at Lender’s option, the cost of obtaining a new Lender’s policy
of title acceptable to Lender insuring the Loan Documents as affected by this Agreement. 

2.6        Release and Covenant Not To Sue. Each of Borrower
Parties, as to itself and all of its respective heirs, successors and assigns only, hereby remises, releases, acquits, satisfies and forever discharges Lender Parties from any and all manner of debts, accountings, bonds, warranties, representations,
covenants, promises, contracts, controversies, agreements, liabilities, obligations, expenses, damages, judgments, executions, actions, inactions, claims, demands and causes of action of any nature whatsoever, at law or in equity, known or unknown,
either now accrued or subsequently maturing, which any of Borrower Parties now has or hereafter can, shall or may have by reason of any matter, cause or thing, from the beginning of the world to and including the date of execution of this Agreement
(“Acquisition Date”), including, without limitation, matters arising out of or relating to (a) the Loan (b) the Loan Documents, and (c) the Project. Each of Borrower Parties, as to itself and all of its respective
heirs, successors and assigns only, covenants and agrees never to institute or cause to be instituted or continue prosecution of any suit or other form of action or proceeding of any kind or nature whatsoever against any of Lender Parties by reason
of or in connection with any of the foregoing matters, claims or causes of action arising during the period from the beginning of the world to the Acquisition Date. As further consideration for the agreements herein contained, each of Borrower
Parties, hereby agrees, represents and warrants that the matters released in this Agreement are not limited to matters which are known or disclosed, and each of Borrower Parties hereby waives any and all rights and benefits with respect to any
matters arising out of or relating to any matter, cause or thing, from the beginning of the world to and including the Acquisition Date, including without limitation matters arising out of or relating to (i) the Loan, (ii) the Loan
Documents, and (iii) the Project which any of Borrower Parties now have, or in the future may have, conferred upon any of Borrower Parties by virtue of the provisions of Section 1542 of the Civil Code of the State of California which
provides as follows: 
 A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES NOT KNOW OR SUSPECT
TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE, WHICH IF KNOWN BY HIM OR HER MUST HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR. 
 In this connection, each of Borrower Parties hereby agrees, represents, and warrants that it realizes and acknowledges that factual matters now unknown to one or more of the Borrower Parties may have
given or may hereafter give rise to causes of action, claims, demands, debts, controversies, damages, costs, losses and expenses which are presently unknown, unanticipated and unsuspected, and each of Borrower Parties further agrees, represents and
warrants that the release herein contained has been negotiated and agreed upon in light of that realization and that Borrower Parties nevertheless hereby intends to release, discharge and acquit all parties so released from any such unknown claims.

  
 11 

 2.7        Further
Assurances. Borrower Parties shall execute and deliver to Lender such agreements, instruments, documents, financing statements and other writings as may be requested from time to time by Lender to perfect and to maintain the perfection of
Lender’s security interest in and to the Project, and to consummate the transactions contemplated by or in the Loan Documents and this Agreement. 
 ARTICLE 3 
 ADDITIONAL PROVISIONS 

3.1        Modifications to Loan Documents 

(a)        Loan Agreement. 

(i)                   
 Notwithstanding any provision in any Loan Document, the following transfers shall constitute permitted transfers (subject only to any conditions set forth below) and shall not require Lender’s consent: 

(1)                   
 the issuance sale, conveyance, transfer or other disposition (each, a “REIT Share Transfer”) of any shares of common stock (the “REIT Shares”) in the REIT so long as (A) at the time of the REIT Share
Transfer, the REIT Shares are registered with and subject to the rules and regulations of the Securities Exchange Act of 1934 (the “Exchange Act”) and either (i) sold through brokerdealers, financial advisors or registered investment
advisers who are registered with the Securities and Exchange Commission (the “SEC”) or the Financial Industry Regulatory Authority (“FINRA”) or (ii) otherwise sold in a private placement offering exempt from
registration under the Securities Act of 1933 (the “Securities Act”), and (B) the REIT Share Transfer does not result in or cause a Change of Control; 

(2)                   
 the issuance, sale, conveyance, transfer or other disposition (each an “OP Transfer”), of any limited partnership interests (the “OP Interests “) in the Operating Partnership so long as (A) at the time of
the OP Transfer, the REIT Shares are registered with and subject to the rules and regulations of the Exchange Act, and either (i) sold through brokerdealers, financial advisors or registered investment advisers who are registered with the SEC
or FINRA or (ii) otherwise sold in a private placement offering exempt from registration under the Securities Act, and (B) the OP Transfer does not result in or cause a Change of Control; 

For purposes of this Section, a “Change of Control” shall occur when: (i) the Operating Partnership is no longer
the sole member of Borrower, (ii) the REIT is no longer the sole general partner of the Operating Partnership, (iii) the REIT and OP are no longer the guarantors/indemnitors of the Loan, (iv) one person (as such term is defined in the
Security Instrument) or group of affiliated persons, other than the REIT, acquires more than 49% of the REIT Shares or the OP interests in one or a series of transactions, (v) the successor to The GC Net Lease REIT Advisor, LLC,
a Delaware limited liability company (the “REIT Advisor”) is not approved in writing by Lender pursuant to Section 3.1(a)(ii) below, (vi) Griffin Capital no 

  
 12 

 
longer owns, directly or indirectly, at least 51% of the REIT Advisor, (vii) Shields no longer owns, directly or indirectly, at least 51% of the REIT Advisor, or (viii) if the REIT
enters into a merger, consolidation or other business combination, or a sale of all or substantially all of the REIT’s assets and/or ownership interests which results in the REIT or the OP not being the surviving entity or Borrower otherwise no
longer being controlled by the REIT. 
 In addition to the occurrence of any of the foregoing events causing a “Change of
Control,” the occurrence of any of the foregoing events, without first obtaining Lender’s written consent, shall also constitute a prohibited transfer resulting in (i) an Event of Default under Section 9.1(d) of the Security
Instrument, (ii) an event for which Borrower shall become liable for the entire Debt under Section 10(a)(i)(B) of the Note, and (iii) an event for which New Indemnitor shall become liable for the entire Debt under clause (v) of
the paragraph following Section 1.2(A)(g) of the Guaranty. 

(ii)                   
 Change in REIT Advisor. In the event that the independent directors of the REIT decide (in accordance with their fiduciary responsibility under applicable law) to cause the REIT to terminate the Advisory Agreement with the REIT Advisor,
New Borrower shall provide or shall cause the REIT to provide written notice to Lender of such termination on or before the effective date thereof and shall solicit the prior written consent of Lender prior to selecting a successor advisor for the
REIT. The successor advisor shall be reasonably acceptable to Lender. New Borrower shall submit or shall cause the REIT to submit a request to Lender for approval of the successor advisor on or before the effective date of the termination of REIT
Advisor or any previously approved successor advisor to REIT Advisor. Lender shall grant or deny such request within sixty (60) days of its receipt of the request and all information Lender requires to evaluate and process the consent for the
successor advisor. If Lender fails to respond within such sixty (60) day period, such failure shall be deemed the consent and approval of Lender of the successor advisor if (A) if New Borrower has delivered to Lender the applicable
information with the notation “FAILURE TO RESPOND TO THIS APPROVAL REQUEST WITHIN SIXTY (60) DAYS FROM RECEIPT SHALL BE DEEMED TO BE LENDER’S APPROVAL,” prominently displayed in bold, all caps in fourteen point font or larger in
the transmittal letter requesting approval, and (B) Lender does not approve or reject the request within sixty (60) days from the date Lender receives the request and the required information. 

(iii)                   
 Tenant in Common Provisions. Sections 8.4(f), (g), (h), and (i) and all of Article 22 of the Security Instrument (and any capitalized terms defined therein) and any of the other Loan Documents that may refer to such sections or
defined terms are hereby deleted in their entirety. 

(iv)                   
 Other TIC Related Terms. All references in the Security Instrument and the other Loan Documents to the terms, “tenant in common,” “tenant-in-common,” “Individual Borrower,” “co-tenancy” and similar
words relating to the tenant in common ownership of the Project are also hereby deleted in its entirety. 

(v)                   
 Kevin Shields. Shields hereby agrees that so long as the Loan is outstanding, Shields shall maintain not less than Two Million Two Hundred Twenty Seven Thousand Seven Hundred Eighty Four (2,227,784) units of limited partnership
interests in 

  
 13 

 
the Operating Partnership, having an initial book value, as determined under GAAP, equal to at least $22,000,000.00. 

     (b)        Cash Management Agreement.

         (i)          
      All references to the term “Deposit Account” in the Cash Management Agreement (as defined in Exhibit B attached hereto) and in any of the other Loan Documents shall hereafter mean and refer to the Deposit
Account described and defined in that certain Deposit Account Control Agreement dated as of the date hereof, among Borrower, Lender, PNC Bank, National Association and Midland Loan Services, a division of PNC Bank, National Association 

         (ii)          
      Notwithstanding anything in Section 3.1 of the Cash Management Agreement to the contrary, all funds on deposit in the Deposit Account shall be disbursed in the same order of priority as such funds would be
disbursed under Section 3.2 of the Cash Management Agreement, provided, however, that until an actual Cash Sweep Trigger occurs, all funds remaining in the Deposit Account, after application of such funds under clauses (i) through
(vii) of Section 3.2, shall be disbursed to or at the direction of New Borrower. 

         (iii)          
      The last paragraph of Section 3.2 the Cash Management Agreement is hereby deleted in its entirety. 
      (c)        References to Loan Documents. All references in the Security Instrument and the other Loan Documents to the Security
Instrument and the other Loan Documents shall hereafter mean and refer to the Security Instrument and the other Loan Documents, as modified by the terms hereof. 

3.2        Consent of Lender. Subject to the terms of this
Agreement, Lender hereby consents to the Requested Actions. Borrower Parties agree that this Agreement shall not be deemed an agreement by Lender to consent to any other transfer or conveyance of the Project or assumption of the Loan, or a consent
to any secondary financing or secondary encumbrance on the Project or New Borrower or any interests in New Borrower. 
 3.3        Release of Current Indemnitor and Original Borrower. By its execution hereof, Lender hereby releases (a) Individual Guarantors (as
defined in the Joinder by and Agreement of Current Guarantors attached hereto (the “Current Guarantor Joinder”)) from their respective obligations under the Guaranty (as defined in Exhibit B attached hereto) from and after the
Acquisition Date in accordance with and subject to the terms of the Current Guarantor Joinder and (b) Original Borrower for any acts or events occurring or obligations arising under the Loan Documents after the Acquisition Date with the
exception of any liability of an Original Borrower based upon (i) any material misrepresentation of such Original Borrower in this Agreement or any other document executed in connection herewith and/or ((ii)) any of their environmental
obligations under Section 1.2(A) of the Guaranty (“Environmental Indemnity Obligations Under Guaranty”) that are caused by such Original Borrower or any of their agents or result from the existence of conditions existing prior
to the Acquisition Date or migrating to or from any portion of the Project prior to the Acquisition Date, or result from a violation of Environmental Law (as defined in the Loan Documents) prior to the Acquisition

  
 14 

 
Date. Original Borrower shall bear the burden of proving when Hazardous Substances (as defined in the Loan Documents) first existed upon, about or beneath the Project or began migrating to
or from the Project and when a violation of Environmental Law first occurred; provided, however, the foregoing burden of proof is for the benefit of the Lender, its successors and assigns, and is not for the benefit of any other party. 

3.4        UCC Filings. New Borrower hereby grants and confirms
unto Lender a first lien priority interest in all of New Borrower’s personal property and all of the fixtures located at the Project to the maximum extent permitted by the Uniform Commercial Code (“UCC”). Borrower Parties
hereby consent to the filing of any financing statements or UCC forms required to be filed in the applicable states or any other applicable filing office, including, but not necessarily limited to, the state of organization of New Borrower and in
the Records (collectively “Filings”) in order to perfect or continue the perfection of said interest and, notwithstanding anything contained in any of the Loan Documents to the contrary, in accordance with the UCC, as amended
subsequent to the making of the Loan, said Filings may be made by Lender without the consent or signature of either of the Borrower Parties. 
 3.5        References to Loan Documents. All references to the term “Loan Documents” in the Security Instrument and the other Loan Documents
shall hereinafter be modified to include this Agreement and all documents executed and/or required in connection with the Requested Actions. 
 ARTICLE 4 
 MISCELLANEOUS PROVISIONS 

4.1        No Limitation of Remedies. No right, power or remedy
conferred upon or reserved to or by Lender in this Agreement is intended to be exclusive of any other right, power or remedy conferred upon or reserved to or by Lender under this Agreement, the Loan Documents or at law, but each and every remedy
shall be cumulative and concurrent, and shall be in addition to each and every other right, power and remedy given under this Agreement, the Loan Documents or now or subsequently existing at law. 

4.2        No Waivers. Except as otherwise expressly set forth in
this Agreement, nothing contained in this Agreement shall constitute a waiver of any rights or remedies of Lender under the Loan Documents or at law. No delay or failure on the part of any party hereto in the exercise of any right or remedy under
this Agreement shall operate as a waiver, and no single or partial exercise of any right or remedy shall preclude other or further exercise thereof or the exercise of any other right or remedy. No action or forbearance by any party hereto contrary
to the provisions of this Agreement shall be construed to constitute a waiver of any of the express provisions. Any party hereto may in writing expressly waive any of such party’s rights under this Agreement without invalidating this Agreement.

 4.3        Successors or Assigns. Whenever any party is
named or referred to in this Agreement, the heirs, executors, legal representatives, successors, successors-in-title and assigns of such party shall be included. All covenants and agreements in this Agreement shall bind and

  
 15 

 
inure to the benefit of the heirs, executors, legal representatives, successors, successors-in-title and assigns of the parties, whether so expressed or not. 

4.4        Construction of Agreement. Each party hereto
acknowledges that it has participated in the negotiation of this Agreement and no provision shall be construed against or interpreted to the disadvantage of any party hereto by any court or other governmental or judicial authority by reason of such
party having or being deemed to have structured, dictated or drafted such provision. Borrower Parties at all times have had access to an attorney in the negotiation of the terms of and in the preparation and execution of this Agreement and have had
the opportunity to review and analyze this Agreement for a sufficient period of time prior to execution and delivery. No representations or warranties have been made by or on behalf of Lender, or relied upon by Borrower Parties, pertaining to the
subject matter of this Agreement, other than those set forth in this Agreement. All prior statements, representations and warranties, if any, are totally superseded and merged into this Agreement, which represents the final and sole agreement of the
parties with respect to the subject matters. All of the terms of this Agreement were negotiated at arm’s length, and this Agreement was prepared and executed without fraud, duress, undue influence or coercion of any kind exerted by any of the
parties upon the others. The execution and delivery of this Agreement are the free and voluntary act of Borrower Parties. 
 4.5        Invalid Provision to Affect No Others. If, from any circumstances whatsoever, fulfillment of any provision of this Agreement or any related
transaction at the time performance of such provision shall be due, shall involve transcending the limit of validity presently prescribed by any applicable usury statute or any other applicable law, with regard to obligations of like character and
amount, then ipso facto, the obligation to be fulfilled shall be reduced to the limit of such validity. If any clause or provision operates or would prospectively operate to invalidate this Agreement, in whole or in part, then such
clause or provision only shall be deemed deleted, as though not contained herein, and the remainder of this Agreement shall remain operative and in full force and effect. 

4.6        Notices. Except as otherwise specifically provided to
the contrary, any and all notices, elections, approvals, consents, demands, requests and responses (“Communications”) permitted or required to be given under this Agreement and the Loan Documents shall not be effective unless in
writing, signed by or on behalf of the party giving the same, and sent by certified or registered mail, postage prepaid, return receipt requested, or by hand delivery or a nationally recognized overnight courier service (such as FedEx), to the party
to be notified at the address of such party set forth below or at such other address within the continental United States as such other party may designate by notice specifically designated as a notice of change of address and given in accordance
with this Section. Any Communications shall be effective upon the earlier of their receipt or three days after mailing in the manner indicated in this Section. Receipt of Communications shall occur upon actual delivery but if attempted delivery is
refused or rejected, the date of refusal or rejection shall be deemed the date of receipt. Any Communication, if given to Lender, must be addressed as follows, subject to change as provided above: 

WELLS FARGO BANK, N.A., AS TRUSTEE 

c/o Midland Loan Services, Inc. 
 CMBS Asset Management 

  
 16 

 10851 Mastin 

Overland Park, Kansas 66210 
 Re: JPMCC 2006-LDP6; Loan No.: 030256201 
 With a copy to: 

LNR Partners, LLC 
 1601 Washington Avenue, Suite 700 
 Miami Beach, Florida 33139

 Attn: Director of Servicing 

Re: JPMCC 2006-LDP6 Loan No.: 030256201 
 and, if given to Original Borrower, must be addressed as follows, notwithstanding any other address set forth in the Loan Documents to the contrary, subject to change as provided above: 

c/o Griffin Capital 
 2121 Rosecrans Avenue, Suite 3321 
 El Segundo, California 90245

 Attn: Kevin A. Shields 

Facsimile: (310) 606-5910 
 With a copy to: 
 Mary Higgins, Esq. 

c/o Griffin Capital 
 790 Estate Drive, Suite 180 
 Deerfield, IL 60015 

Facsimile: (847) 267-1237 
 and, if given to New Borrower, must be addressed as follows, subject to change as provided above: 
 The GC Net Lease (Carlsbad) Investors, LLC 
 c/o Griffin Capital

 2121 Rosecrans Avenue, Suite 3321 

El Segundo, California 90245 
 Attn: Kevin A. Sheilds 
 Facsimile: (310) 606-5910

 With a copy to: 
 Mary Higgins, Esq. 
 c/o Griffin Capital 

790 Estate Drive, Suite 180 
 Deerfield, IL 60015 
 Facsimile: (847) 267-1237 

4.7        Governing Law. This Agreement shall be interpreted,
construed and enforced in accordance with the laws of the State in which the Project is located. 

  
 17 

 4.8        Headings;
Exhibits. The headings of the articles, sections and subsections of this Agreement are for the convenience of reference only, are not to be considered a part of this Agreement and shall not be used to construe, limit or otherwise affect this
Agreement. 
 4.9        Modifications. The terms of this
Agreement may not be changed, modified, waived, discharged or terminated orally, but only by an instrument or instruments in writing, signed by the Party against whom the enforcement of the change, modification, waiver, discharge or termination is
asserted. Lender’s consent to the Requested Actions shall not be deemed to constitute Lender’s consent to any provisions of the organizational documents that would be in violation of the terms and conditions of any of the Loan Documents.

 4.10      Time of Essence; Consents. Time is of the essence of
this Agreement and the Loan Documents. Any provisions for consents or approvals in this Agreement shall mean that such consents or approvals shall not be effective unless in writing and executed by Lender. 

4.11      Counterparts. This Agreement may be executed in two or more
counterparts, each of which shall be deemed an original, but all of which will constitute the same agreement. Any signature page of this Agreement may be detached from any counterpart of this Agreement without impairing the legal effect of any
signatures thereon and may be attached to another counterpart of this Agreement identical in form hereto but having attached to it one or more additional signature pages. 

4.12      New Guarantor Joinder. New Guarantor (as defined in the Joinder By
and Agreement of New Guarantor attached hereto) shall assume the obligations of Current Sponsor Guarantor (as defined in the Current Guarantor Joinder) under the Guaranty pursuant to the Joinder by and Agreement of New Guarantor attached hereto.

 4.13      WAIVER OF TRIAL BY
JURY. TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, BORROWER PARTIES HEREBY AGREE NOT TO ELECT A TRIAL BY JURY OF ANY ISSUE TRIABLE OF RIGHT BY JURY, AND WAIVE ANY RIGHT TO TRIAL BY JURY FULLY TO THE EXTENT THAT ANY SUCH RIGHT SHALL
NOW OR HEREAFTER EXIST WITH REGARD TO THE SECURITY INSTRUMENT, THE NOTE, THIS AGREEMENT OR THE OTHER LOAN DOCUMENTS, OR ANY CLAIM, COUNTERCLAIM OR OTHER ACTION ARISING IN CONNECTION THEREWITH INCLUDING, BUT NOT LIMITED TO THOSE RELATING TO
(A) ALLEGATIONS THAT A PARTNERSHIP EXISTS BETWEEN LENDER AND BORROWER; (B) USURY OR PENALTIES OR DAMAGES THEREFOR; (C) ALLEGATIONS OF UNCONSCIONABLE ACTS, DECEPTIVE TRADE PRACTICE, LACK OF GOOD FAITH OR FAIR DEALING, LACK OF
COMMERCIAL REASONABLENESS, OR SPECIAL RELATIONSHIPS (SUCH AS FIDUCIARY, TRUST OR CONFIDENTIAL RELATIONSHIP); (D) ALLEGATIONS OF DOMINION, CONTROL, ALTER EGO, INSTRUMENTALITY, FRAUD, REAL ESTATE FRAUD, MISREPRESENTATION, DURESS, COERCION, UNDUE
INFLUENCE, INTERFERENCE OR NEGLIGENCE; (E) ALLEGATIONS OF TORTIOUS INTERFERENCE WITH PRESENT OR PROSPECTIVE BUSINESS RELATIONSHIPS OR OF ANTITRUST; OR (F) SLANDER, LIBEL OR DAMAGE TO REPUTATION. TO THE FULLEST EXTENT PERMITTED BY
APPLICABLE LAW, 

  
 18 

 
THIS WAIVER OF RIGHT TO TRIAL BY JURY IS GIVEN KNOWINGLY AND VOLUNTARILY BY BORROWER PARTIES, AND IS INTENDED TO ENCOMPASS INDIVIDUALLY EACH INSTANCE AND EACH ISSUE AS TO WHICH THE RIGHT TO A
TRIAL BY JURY WOULD OTHERWISE ACCRUE. LENDER IS HEREBY AUTHORIZED TO FILE A COPY OF THIS PARAGRAPH IN ANY PROCEEDING AS CONCLUSIVE EVIDENCE OF THIS WAIVER BY BORROWER PARTIES. 

(REMAINDER OF PAGE INTENTIONALLY LEFT BLANK) 

  
 19 

 The parties have executed and delivered this Agreement as of the day and
year first above written. 
  

					
	LENDER:
	
	 WELLS FARGO BANK, N.A., A NATIONAL BANKING ASSOCIATION, AS TRUSTEE FOR THE REGISTERED HOLDERS OF J.P. MORGAN CHASE COMMERCIAL MORTGAGE SECURITIES
CORP., COMMERCIAL MORTGAGE PASS-THROUGH CERTIFICATES, SERIES 2006-LDP6

		
	 By:
	  	 LNR Partners, LLC, a Florida limited liability company, successor by statutory conversion to LNR Partners, Inc., a Florida corporation, as
attorney-in-fact

			
		  	 By:
	 	 /s/ Randolph J. Wolpert

		  		 	 Randolph J. Wolpert, Vice President

		  		 	[notarized]

 The parties have executed and delivered this Agreement as of the day and
year first above written. 
  

					
	ORIGINAL BORROWER:
	
	GRIFFIN CAPITAL (CARLSBAD POINTE) INVESTORS, LLC, a Delaware limited liability company
		
	 By:
	  	 Griffin Capital Corporation, a California corporation,

	 Its:
	  	 Sole Member

			
		  	 By:
	 	 /s/ Kevin A. Shields

		  		 	 Kevin A. Shields, CEO

		  		 	[notarized]

 The parties have executed and delivered this Agreement as of the day and
year first above written. 
  

	
	TIC 1 – TIC 29:
	
	 [executed by an authorized signatory]

	[notarized]

 The parties have executed and delivered this Agreement as of the day and
year first above written. 
  

							
	NEW BORROWER:
	
	 THE GC NET LEASE (CARLSBAD) INVESTORS, LLC, a Delaware limited liability company

		
	 By:
	  	 The GC Net Lease REIT Operating Partnership, L.P., a Delaware limited partnership, its Sole Member

			
		  	 By:
	 	 The GC Net Lease REIT, Inc.,

		  		 	 a Maryland corporation,

		  		 	 its General Partner

				
		  		 	 By:
	 	 /s/ Kevin A. Shields

		  		 		 	 Kevin A. Shields, President

		  		 		 	[notarized]Employment Agreement with Martha Carter, dated February 14, 2011

 Exhibit 10.1 
 EMPLOYMENT AGREEMENT 
 This Employment Agreement (this
“Agreement”) is made and entered into as of this 14th day of February 2011, by and between Aegerion Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Martha J. Carter (the
“Employee”). 
 W I T N E S S E T H:

 WHEREAS, the Company desires to employ Employee and to enter into this Agreement embodying the terms of such employment, and
Employee desires to enter into this Agreement and to accept such employment, subject to the terms and provisions of this Agreement. 
 NOW, THEREFORE, in consideration of the promises and mutual covenants contained herein and for other good and valuable consideration, the receipt and sufficiency of which are mutually acknowledged, the
Company and Employee hereby agree as follows: 
 Section 1. Definitions. 

(a) “Accrued Obligations” shall mean (i) all accrued but unpaid Base Salary through the Date of Termination,
(ii) any unpaid or unreimbursed expenses incurred in accordance with Section 6 hereof, and (iii) any accrued but unused vacation time through the Date of Termination. 

(b) “Base Salary” shall mean the salary provided for in Section 4(a) hereof. 

(c) “Board” shall mean the Board of Directors of the Company. 

(d) “Confidentiality Agreement” shall mean the Company’s Confidentiality, Assignment and Noncompetition Agreement
attached hereto as Exhibit A. 
 (e) “Cause” shall mean (i) Employee’s failure (except where
due to a Disability), neglect or refusal to perform in any material respect Employee’s duties and responsibilities, (ii) any act of Employee that has, or could reasonably be expected to have, the effect of injuring the business of the
Company or its affiliates in any material respect, (iii) Employee’s conviction of. or plea of guilty or no contest to: (x) a felony or (y) any other criminal charge that has, or could be reasonably expected to have, an adverse
impact on the performance of Employee’s duties to the Company or otherwise result in material injury to the reputation or business of the Company, (iv) the commission by Employee of an act of fraud or embezzlement against the Company, or
any other act that creates or reasonably could create negative or adverse publicity for the Company; (v) any violation by Employee of the policies of the Company, including but not limited to those relating to sexual harassment or business
conduct, and those otherwise set forth in the manuals or statements of policy of the Company, (vi) Employee’s violation of federal or state securities laws, or (vii) Employee’s breach of this Agreement or breach of the
Confidentiality Agreement. 
 (f) “Code” shall mean the Internal Revenue Code of 1986, as amended, and the
rules and regulations promulgated thereunder. 

 Confidential 
  

 (g) “Date of Termination” shall mean the date on which Employee’s
employment terminates. 
 (h) “Disability” shall mean any physical or mental disability or infirmity of
Employee that prevents the performance of Employee’s duties for a period of (i) ninety (90) consecutive days or (ii) one hundred twenty (120) non-consecutive days during any twelve (12) month period. Any question as to
the existence, extent, or potentiality of Employee’s Disability upon which Employee and the Company cannot agree shall be determined by a qualified, independent physician selected by the Company and approved by Employee (which approval shall
not be unreasonably withheld). The determination of any such physician shall be final and conclusive for all purposes of this Agreement. 
 (i) “Effective Date” shall mean February 14, 2011. 
 (j) “Good Reason” shall mean, without Employee’s consent, (i) a material diminution in Employee’s material duties or responsibilities, (ii) a material reduction in
Base Salary as set forth in Section 4(a) hereof (other than pursuant to an across-the-board reduction applicable to all similarly situated executives), (iii) the relocation of Employee’s principal place of employment more than fifty
(50) miles from its current location, or (iv) any other material breach of a provision of this Agreement by the Company (other than a provision that is covered by clause (i), (ii), or (iii) above). Employee acknowledges and agrees
that Employee’s exclusive remedy in the event of any breach of this Agreement shall be to assert Good Reason pursuant to the terms and conditions of Section 7(e) hereof. Notwithstanding the foregoing, during the Term, in the event that the
Company reasonably believes that Employee may have engaged in conduct that could constitute Cause hereunder, the Company may, in its sole and absolute discretion, suspend Employee from performing Employee’s duties hereunder, and in no event
shall any such suspension constitute an event pursuant to which Employee may terminate employment with Good Reason or otherwise constitute a breach hereunder; provided, that no such suspension shall alter the Company’s obligations under
this Agreement during such period of suspension. 
 (k) “Release of Claims” shall mean a separation agreement
in a form acceptable to the Company under which Employee releases the Company from any and all claims and causes of action and the execution of which is a condition precedent to Employee’s eligibility for Severance Benefits in the event his
employment is terminated by the Company without Cause or by Employee for Good Reason, as described in Sections 7(d) and 7(e). 

(l) “Severance Benefits” shall mean (i) continued payment of Base Salary during the Severance Term, payable in
accordance with the Company’s regular payroll practices; and (ii) subject to the Employee’s timely election of COBRA and copayment of premium amounts at the active employees’ rate, payment of the employer portion of the premiums
for the Company’s group health and dental program for the Employee in order to allow him to continue to participate in the Company’s group health and dental program until the earlier of (Y) 12 months from the Date of Termination, and
(Z) the date the Employee becomes re-employed and eligible for health and/or dental insurance. 

  
 2 

 Confidential 
  

 (m) “Severance Term” shall mean the 12 month period, which commences on
the first pay day that is at least thirty-five (35) days from the Date of Termination following termination by the Company without Cause or by Employee for Good Reason. 
 Section 2. Acceptance and Term. 
 The Company agrees to employ Employee
on an at-will basis, and Employee agrees to accept such employment and serve the Company, in accordance with the terms and conditions set forth herein. The term of employment (referred to herein as the “Term”) shall commence on the
Effective Date and shall continue until terminated by either party at any time, subject to the provisions herein. 

Section 3. Position, Duties, and Responsibilities; Place of Performance. 

(a) Position, Duties, and Responsibilities. During the Term, Employee shall be employed and serve as Chief Regulatory Officer and
Senior Vice President of the Company (together with such other position or positions consistent with Employee’s title or as the Company shall specify from time to time) and shall have such duties and responsibilities commensurate therewith, and
such other duties as may be assigned and/or prescribed from time to time by the Chief Executive Officer and/or the Board. 
 (b)
Performance. Employee shall devote his full business time, attention, skill, and best efforts to the performance of his duties under this Agreement and shall not engage in any other business or occupation during the Term, including, without
limitation, any activity that (x) conflicts with the interests of the Company, (y) interferes with the proper and efficient performance of Employee’s duties for the Company, or(z) interferes with Employee’s exercise of judgment
in the Company’s best interests. Notwithstanding the foregoing, nothing herein shall preclude Employee from (i) serving, with the prior written consent of the Board, as a member of the boards of directors or advisory boards (or their
equivalents in the case of a non-corporate entity) of non-competing businesses and charitable organizations, (ii) engaging in charitable activities and community affairs, and (iii) managing Employee’s personal investments and affairs;
provided, however, that the activities set out in clauses (i), (ii), and (iii) shall be limited by Employee so as not to interfere, individually or in the aggregate, with the performance of Employee’s duties and responsibilities
hereunder. Employee represents that he has provided the Company with a comprehensive list of all outside professional activities with which he is currently involved or reasonably expects to become involved. In the event that, during his employment
by the Company, the Employee desires to engage in other outside professional activities, not included on such list, Employee will first seek written approval from the CEO or President and such approval shall not be unreasonably withheld. 

Section 4. Compensation. 
 (a) Base Salary. In exchange for Employee’s satisfactory performance of his duties and responsibilities, Employee initially shall be paid a bi-weekly Base Salary of $10,576.92 ($275,000 on an
annualized basis), payable in accordance with the regular payroll practices of the Company. All payments in this Agreement are on a gross, pre-tax basis and shall be subject to all applicable federal, state and local withholding, payroll and other
taxes. 

  
 3 

 Confidential 
  

 (b) Bonus Eligibility. In addition to your Base Salary, you will be eligible for
the following bonus compensation: 
 (i) Target Bonus: Employee will be eligible to earn an annual target
bonus of up to 30% of your Base Salary (the “Target Bonus”). The actual amount of such bonus, if any, will be determined by the Board and Employee’s manager in their sole discretion, based upon Company performance,
Employee’s achievement of a series of performance milestones, and any other factors that the Board, in its discretion, deem appropriate. Please note that Employee’s achievement of such milestones, as well as the amount of any bonus, shall
be determined by the Board and Employee’s manager in their sole discretion. Typically, bonuses, if any, are paid out no later than March 15 of the year following the applicable bonus year, Except as specifically set forth in
Section 7, please also note that Employee must be employed by Aegerion at the time of any such bonus payment in order to be eligible for any such payment. 
 (ii) Milestone Bonus: In addition, Employee also will be eligible to receive a cash bonus equal to 5% of his Base Salary upon the occurrence of each of the following events (the “Milestone
Bonus”): (1) approval of Lomitapide by the U.S. Food and Drug Administration (the “FDA”), and (2) approval of Lomitapide by the European Medicines Agency (the “EMA”). These bonuses, if any, will
be paid out following the occurrence of the milestone event to which reference is made in sub-sections 4(b)(ii)(l)-(2) and no later than March 15 of the year following such event. Except as specifically set forth in Section 7,
Employee must be employed by the Company at the time of any such bonus payments in order to be eligible for any such payment. 

(c) Stock Options/Equity Grants. Subject to Board approval, the Company will offer to you the option (the “Initial Option
Award”) to purchase 132,000 shares of the Company’s common stock, $0,001 par value per share (the “Common Stock”). The Initial Option Award shall have an exercise price equal to the fair market value of the Common
Stock on the date of grant (as determined by the Board or Compensation Committee thereof). The Initial Option Award shall be subject to vesting and shall be issued pursuant to the terms of the Company’s 2010 Stock Option and Incentive Plan (or
a successor plan, if any) and subject to the terms of a stock option agreement thereunder (collectively the “Equity Documents”). The vesting schedule for Employee’s Initial Option Award will be the vesting schedules outlined in
the Equity Documents (i.e., the option to purchase 88,000 shares will vest over 4 years in equal monthly installments commencing immediately upon the date of the grant, and the option to purchase 44,000 shares will vest over 4 years in equal monthly
installments commencing upon submission of the NDA and MAA for Lomitapide to the FDA and EMA, respectively). The full terms and conditions related to these option grants shall be set forth in the Equity Documents and to the extent that there is any
inconsistency between this Agreement and the Equity Documents, the Equity Documents shall control. 
 Section 5.
Employee Benefits. 
 During the Term, Employee shall be eligible to participate in health insurance and other benefits
provided generally to similarly situated employees of the Company, subject to the terms and conditions of the applicable benefit plans (which shall govern). Employee also shall be 

  
 4 

 Confidential 
  

 
eligible to accrue up to four weeks of vacation and the same number of holidays as well as any other benefits, in each case as are generally allowed to similarly situated employees of the Company
in accordance with the Company policy as in effect from time to time. Nothing contained herein shall be construed to limit the Company’s ability to amend, suspend, or terminate any employee benefit plan or policy at any time without providing
Employee notice, and the right to do so is expressly reserved. 
 Section 6. Reimbursement of Business Expenses.

 During the Term of Employment, the Company shall pay (or promptly reimburse Employee) for documented, out-of-pocket expenses
reasonably incurred by Employee in the course of performing his duties and responsibilities hereunder, which are consistent with the Company’s policies in effect from time to time with respect to business expenses, subject to the Company’s
requirements with respect to reporting of such expenses. 
 Section 7. Termination of Employment. 

(a) General. Employee’s employment with the Company shall terminate upon the earliest to occur of any of the following
(whether before or after a “Sale Event,” as that term is defined in the 2010 Stock Option and Incentive Plan): (i) Employee’s death, (ii) a termination by reason of a Disability, (iii) a termination by the Company with
or without Cause, and (iv) a termination by Employee with or without Good Reason. Notwithstanding anything herein to the contrary, the payment (or commencement of a series of payments) hereunder of any nonqualified deferred compensation (within
the meaning of Section 409A of the Code) upon a termination of employment shall be delayed until such time as Employee has also undergone a “separation from service” as defined in Treas. Reg. 1.409A-l(h), at which time such
nonqualified deferred compensation (calculated as of the date of Employee’s termination of employment hereunder) shall be paid (or commence to be paid) to Employee on the schedule set forth in this Section 7 as if Employee had undergone
such termination of employment (under the same circumstances) on the date of Employee’s ultimate “separation from service.” 
 (b) Termination Due to Death or Disability. Employee’s employment under this Agreement shall terminate automatically upon Employee’s death. The Company also may terminate Employee’s
employment immediately upon the occurrence of a Disability, such termination to be effective upon Employee’s receipt of written notice of such termination. In the event of Employee’s termination as a result of Employee’s death or
Disability, Employee or Employee’s estate or beneficiaries, as the case may be, shall be entitled only to the following: (i) the Accrued Obligations; (ii) if the Date of Termination occurs between January 1 and March 15
following the immediately preceding calendar year, then Employee shall be eligible to receive her earned Target Bonus, if any, and (iii) if the Date of Termination occurs after the Milestone Bonus has been earned, but before it has been paid,
then Employee shall be eligible to receiver her earned Milestone Bonus, paid out in a manner consistent with the Company’s bonus compensation practices then if effect. Employee shall have no further rights to any compensation or any other
benefits under this Agreement. 

  
 5 

 Confidential 
  

 (c) Termination by the Company with Cause. 

(i) The Company may terminate Employee’s employment at any time with Cause, effective upon Employee’s receipt of
written notice of such termination; provided, however, that with respect to any Cause termination relying on clause (i) or (ii) of the definition of Cause set forth in Section 1(d) hereof, to the extent that such act or acts or
failure or failures to act are curable, Employee shall be given ten (10) days’ written notice by the Company of its intention to terminate him with Cause, such notice to state the act or acts or failure or failures to act that constitute
the grounds on which the proposed termination with Cause is based, and such termination shall be effective at the expiration of such ten (10) day notice period unless Employee has fully cured such act or acts or failure or failures to act, to
the Company’s complete satisfaction, that give rise to Cause during such period. 
 (ii) In the event that
the Company terminates Employee’s employment with Cause, Employee shall be entitled only to the Accrued Obligations. Following such termination of Employee’s employment with Cause, except as set forth in this Section 7(c)(ii),
Employee shall have no further rights to any compensation or any other benefits under this Agreement. For the avoidance of doubt, Employee’s sole and exclusive remedy upon a termination of employment by the Company with Cause shall be receipt
of the Accrued Obligations. 
 (d) Termination by the Company without Cause. The Company may terminate Employee’s
employment at any time without Cause, effective upon Employee’s receipt of written notice of such termination. In the event that Employee’s employment is terminated by the Company without Cause (other than due to death or Disability) and
provided that he fully executes an effective Release of Claims as described in Section 7(g), Employee shall be eligible for the following: 
 (i) The Accrued Obligations; 
 (ii) The Severance Benefits;

 (iii) if the Date of Termination occurs between January 1 and March 15 following the immediately
preceding calendar year, then Employee shall be eligible to receive her earned Target Bonus, if any, 
 (iv) if
the Date of Termination occurs after the Milestone Bonus has been earned, but before it has been paid, then Employee shall be eligible to receive her earned Milestone Bonus, paid out in a manner consistent with the Company’s bonus compensation
practices then if effect; and 
 (v) Acceleration of the vesting of 100% of Employee’s then outstanding
unvested equity awards, such that all unvested equity awards vest and become fully exercisable or non-forfeitable as of the Date of Termination; provided that such termination without Cause and the Dale of Termination occurs within eighteen
(18) months after a Sale Event (the “Accelerated Equity Benefit”), in which case Employee 

  
 6 

 Confidential 
  

 
shall have ninety (90) days from the Date of Termination to exercise the vested equity awards, 
 Notwithstanding the foregoing, the Severance Benefits and the Accelerated Equity Benefit shall immediately terminate, and the Company shall have no further obligations to Employee with respect thereto, in
the event that Employee breaches any provision of the Confidentiality Agreement or the Release of Claims (in addition to any “clawback” rights that the Company may possess, as set forth in the Equity Document). Any such termination of
payment or benefits shall have no effect on the Release of Claims or any of Employee’s post-employment obligations to the Company. Following such termination of Employee’s employment by the Company without Cause, except as set forth in
this Section 7(d), Employee shall have no further rights to any compensation or any other benefits under this Agreement. For the avoidance of doubt, Employee’s sole and exclusive remedy upon a termination of employment by the Company
without Cause shall be receipt of the Severance Benefits (and, in the case of such a termination within eighteen (18) months after a Sale Event, the Accelerated Equity Benefit), subject to his execution of the Release of Claims, and the Accrued
Obligations. 
 In addition, the Severance Benefit set forth in Section l(l)(i) shall be reduced dollar for dollar by any compensation Employee
receives from another employer during the Severance Term. The Employee agrees to give prompt notice of any employment during the Severance term and promptly shall respond to any reasonable inquiries concerning her professional activities. If the
Company makes overpayments of Severance Benefits, Employee promptly shall return any such overpayments to the Company and/or hereby authorizes deductions from future Severance Benefit amounts. The foregoing shall not create any obligation on the
Employee’s part to seek re-employment after the Date of Termination, 
 (e) Termination by Employee with Good
Reason. Employee may terminate his employment with Good Reason by providing the Company thirty (30) days’ written notice setting forth in reasonable specificity the event that constitutes Good Reason, which written notice, to be
effective, must be provided to the Company within sixty (60) days of the occurrence of such event. During such thirty (30) day notice period, the Company shall have a cure right (if curable), and if not cured within such period,
Employee’s termination will be effective upon the expiration of such cure period, and Employee shall be entitled to the same payments and benefits as provided in Section 7(d) hereof for a termination by the Company without Cause, subject
to the same conditions on payment and benefits as described in Section 7(d) hereof. Following such termination of Employee’s employment by Employee with Good Reason, except as set forth in this Section 7(e), Employee shall have no
further rights to any compensation or any other benefits under this Agreement. For the avoidance of doubt, Employee’s sole and exclusive remedy upon a termination of employment with Good Reason shall be receipt of the payments and benefits set
forth in Sections 7(d)(i)-(iv) above (and, in the case of such a termination within eighteen (18) months after a Sale Event, the Accelerated Equity Benefit), subject to his execution of the Release of Claims. 

(f) Termination by Employee without Good Reason. Employee may terminate his employment without Good Reason by providing the
Company thirty (30) days’ written notice of such termination. In the event of a termination of employment by Employee under this Section 7(f), Employee shall be entitled only to the Accrued Obligations. In the event

  
 7 

 Confidential 
  

 
of termination of Employee’s employment under this Section 7(f), the Company may, in its sole and absolute discretion, by written notice accelerate such date of termination without
changing the characterization of such termination as a termination by Employee without Good Reason, Following such termination of Employee’s employment by Employee without Good Reason, except as set forth in this Section 7(f), Employee
shall have no further rights to any compensation or any other benefits under this Agreement. For the avoidance of doubt, Employee’s sole and exclusive remedy upon a termination of employment by Employee without Good Reason shall be receipt of
the Accrued Obligations. 
 (g) Release. Notwithstanding any provision herein to the contrary, the payment of the
Severance Benefits pursuant to subsection (d) or (e) of this Section 7 (other than the Accrued Obligations) shall be conditioned upon Employee’s execution, delivery to the Company, and non-revocation of the Release of Claims (and
the expiration of any revocation period contained in such Release of Claims) in accordance with the time limits set forth therein. If Employee fails to execute the Release of Claims in such a timely manner, or timely revokes Employee’s
acceptance of such release following its execution, Employee shall not be entitled to any of the Severance Benefits. Further, to the extent that any of the Severance Benefits constitutes “nonqualified deferred compensation” for purposes of
Section 409A of the Code, any payment of any amount or provision of any benefit otherwise scheduled to occur prior to the thirty-fifth (35th) day following the date of Employee’s termination of employment hereunder, but for the
condition on executing the Release of Claims as set forth herein, shall not be made until the first regularly scheduled payroll date following such thirty-fifth (35th) day, after which any remaining Severance Benefits shall thereafter be
provided to Employee according to the applicable schedule set forth herein. 
 Section 8. Confidentiality Agreement;
Cooperation. 
 (a) Confidentiality Agreement. As a condition of Employee’s employment with the Company under the
terms of this Agreement, Employee shall execute and deliver to the Company the Confidentiality Agreement, in the form attached hereto as Exhibit A. The parties hereto acknowledge and agree that this Agreement and the Confidentiality Agreement shall
be considered separate contracts. 
 (b) Litigation and Regulatory Cooperation. During and after Employee’s
employment, Employee shall cooperate fully with the Company in the defense or prosecution of any claims or actions now in existence or which may be brought in the future against or on behalf of the Company which relate to events or occurrences that
transpired while the Company employed Employee, provided, that the Employee will not have an obligation tinder this paragraph with respect to any claim in which the Employee has filed directly against the Company or related persons or entities. The
Employee’s full cooperation in connection with such claims or actions shall include, but not be limited lo, being available to meet with counsel to prepare for discovery or trial and to act as a witness on behalf of the Company at mutually
convenient times. During and after Employee’s employment, Employee also shall cooperate fully with the Company in connection with any investigation or review of any federal, state or local regulatory authority as any such investigation or
review relates to events or occurrences that transpired while Employee was employed by the Company, provided Employee will not have any obligation under this paragraph with respect to any claim in which Employee has filed

  
 8 

 Confidential 
  

 
directly against the Company or related persons or entities. The Company shall reimburse Employee for any reasonable out-of-pocket expenses incurred in connection with Employee’s performance
of obligations pursuant to this Section 8(b). 
 Section 9. Taxes. 

The Company may withhold from any payments made under this Agreement all applicable taxes, including but not limited to income,
employment, and social insurance taxes, as shall be required by law. Employee acknowledges and represents that the Company has not provided any tax advice to him in connection with this Agreement and that Employee has been advised by the Company to
seek tax advice from Employee’s own tax advisors regarding this Agreement and payments that may be made to him pursuant to this Agreement, including specifically, the application of the provisions of Section 409A of the Code to such
payments. The Company shall have no liability to Employee or to any other person if any of the provisions of this Agreement are determined to constitute deferred compensation subject to Section 409A but that do not satisfy an exemption from, or
the conditions of, that section. 
 Section 10. Additional Section 409A Provisions. 

Notwithstanding any provision in this Agreement to the contrary: 
 (a) If at the time of the Employee’s separation from service within the meaning of Section 409A of the Code, the Company determines that the Employee is a “specified employee” within
the meaning of Section 409A(a)(2)(B)(i) of the Code, then to the extent any payment or benefit that the Employee becomes entitled to under this Agreement on account of the Employee’s separation from service would be considered deferred
compensation subject to the 20 percent additional tax imposed pursuant to Section 409A(a) of the Code as a result of the application of Section 409A(a)(2)(B)(i) of the Code, such payment shall not be payable and such benefit shall not be
provided until the date that is the earlier of (i) six months and one day after the Employee’s separation from service, or (ii) the Employee’s death. If any such delayed cash payment is otherwise payable on an installment basis,
the first payment shall include a catch-up payment covering amounts that would otherwise have been paid during the six-month period but for the application of this provision, and the balance of the installments shall be payable in accordance with
their original schedule. 
 (b) Each payment in a series of payments hereunder shall be deemed to be a separate payment for
purposes of Section 409A of the Code. Neither the Company nor Employee shall have the right to accelerate or defer the delivery of any such payments except to the extent specifically permitted or required by Section 409A. 

(c) To the extent that any right to reimbursement of expenses or payment of any benefit in-kind under this Agreement constitutes
nonqualified deferred compensation (within the meaning of Section 409A of the Code), (i) any such expense reimbursement shall be made by the Company no later than the last day of the taxable year following the taxable year in which such
expense was incurred by Employee, (ii) the right to reimbursement or in-kind benefits shall not be subject to liquidation or exchange for another benefit, and (iii) the amount of expenses eligible for reimbursement or in-kind benefits
provided during any taxable year shall not affect 

  
 9 

 Confidential 
  

 
the expenses eligible for reimbursement or in-kind benefits to be provided in any other taxable year; provided, that the foregoing clause shall not be violated with regard to expenses reimbursed
under any arrangement covered by Section 105(b) of the Code solely because such expenses are subject to a limit related to the period the arrangement is in effect. 
 (d) To the extent that any payment or benefit described in this Agreement constitutes “non-qualified deferred compensation” under Section 409A of the Code, and to the extent that such
payment or benefit is payable upon the Employee’s termination of employment, then such payments or benefits shall be payable only upon the Employee’s “separation from service.” The determination of whether and when a separation
from service has occurred shall be made in accordance with the presumptions set forth in Treasury Regulation Section 1.409A-1(h). 
 (e) The parties intend that this Agreement will be administered in accordance with Section 409A of the Code. To the extent that any provision of this Agreement is ambiguous as to its compliance with
Section 409A of the Code, the provision shall be read in such a manner so that all payments hereunder comply with Section 409A of the Code. The parties agree that this Agreement may be amended, as reasonably requested by either party, and
as may be necessary to fully comply with Section 409A of the Code and all related rules and regulations in order to preserve the payments and benefits provided hereunder without additional cost to either party. While the payments and benefits
provided hereunder are intended to be structured in a manner to avoid the implication of any penalty taxes under Section 409A of the Code, in no event whatsoever shall the Company or any of its affiliates be liable for any additional tax,
interest, or penalties that may be imposed on Employee as a result of Section 409A of the Code or any damages for failing to comply with Section 409A of the Code (other than for withholding obligations or other obligations applicable to
employers, if any, under Section 409A of the Code). 
 Section 11. Successors and Assigns. 

(a) The Company. This Agreement shall inure to the benefit of the Company and its respective successors and assigns. This Agreement
may be assigned by the Company without Employee’s prior consent. 
 (b) Employee. Employee’s rights and
obligations under this Agreement shall not be transferable by Employee by assignment or otherwise, without the prior written consent of the Company; provided, however, that if Employee shall die, all amounts then payable to Employee hereunder shall
be paid in accordance with the terms of this Agreement to Employee’s devisee, legatee, or other designee, or if there be no such designee, to Employee’s estate. 
 Section 12. Waiver and Amendments. 
 Any waiver, alteration, amendment,
or modification of any of the terms of this Agreement shall be valid only if made in writing and signed by each of the parties hereto; provided, however, that any such waiver, alteration, amendment, or modification must be consented to on the
Company’s behalf by the Board. No waiver by either of the parties hereto of their rights hereunder shall be deemed to constitute a waiver with respect to any subsequent 

  
 10 

 Confidential 
  

 
occurrences or transactions hereunder unless such waiver specifically states that it is to be construed as a continuing waiver. 

Section 13. Severability. 
 If any covenants or such other provisions of this Agreement are found to be invalid or unenforceable by a final determination of a court of competent jurisdiction, (a) the remaining terms and
provisions hereof shall be unimpaired, and (b) the invalid or unenforceable term or provision hereof shall be deemed replaced by a term or provision that is valid and enforceable and that comes closest to expressing the intention of the invalid
or unenforceable term or provision hereof. 
 Section 14. Governing Law and Jurisdiction. 

This is a Massachusetts contract and shall be construed under and be governed in all respects by the laws of the Commonwealth of
Massachusetts without giving effect to the conflict of laws principles of such state. With respect to any disputes concerning federal law, such disputes shall be determined in accordance with the law as it would be interpreted and applied by the
United States Court of Appeals for the First Circuit. To the extent that any court action is initiated to enforce this Agreement, the parties hereby consent to the jurisdiction of the state and federal courts of the Commonwealth of Massachusetts.
Accordingly, with respect to any such court action, Employee (a) submits to the personal jurisdiction of such courts; (b) consents to service of process; and (c) waives any other requirement (whether imposed by statute, rule of court,
or otherwise) with respect to personal jurisdiction or service of process. 
 Section 15. Notices. 

(a) Place of Delivery. Every notice or other communication relating to this Agreement shall be in writing, and shall be mailed to
or delivered to the party for whom or which it is intended at such address as may from time to time be designated by it in a notice mailed or delivered to the other party as herein provided; provided, that unless and until some other address
be so designated, all notices and communications by Employee to the Company shall be mailed or delivered to the Company at its principal executive office, and all notices and communications by the Company to Employee may be given to Employee
personally or may be mailed to Employee at Employee’s last known address, as reflected in the Company’s records. 

(b) Date of Delivery. Any notice so addressed shall be deemed to be given or received (i) if delivered by hand, on the date
of such delivery, (ii) if mailed by courier or by overnight mail, on the first business day following the dale of such mailing, and (iii) if mailed by registered or certified mail, on the third business day after the date of such mailing.

 Section 16. Section Headings. 
 The headings of the sections and subsections of this Agreement are inserted for convenience only and shall not be deemed to constitute a part thereof or affect the meaning or interpretation of this
Agreement or of any term or provision hereof. 

  
 11 

 Confidential 
  

 Section 17. Entire Agreement. 

This Agreement, together with the Confidentiality Agreement attached hereto and the Equity Documents, constitutes the entire understanding
and agreement of the parties hereto regarding the employment of Employee. This Agreement supersedes all prior negotiations, discussions, correspondence, communications, understandings, and agreements between the parties (including any offer letter
given to Employee) relating to the subject matter of this Agreement; provided however, that Employee remains subject to those conditions set forth in the offer letter regarding completion of an employment application and background and/or reference
checks to the Company’s satisfaction, in addition to executing those forms necessary for the processing of such background check. 
 Section 18. Survival of Operative Sections. 
 Upon any termination of
Employee’s employment, the provisions of Section 7 through Section 19 of this Agreement (together with any related definitions set forth in Section 1 hereof) shall survive to the extent necessary to give effect to the provisions
thereof. 
 Section 19. Counterparts. 
 This Agreement may be executed in two or more counterparts, each of which shall be deemed to be an original but all of which together shall constitute one and the same instrument. The execution of this
Agreement may be by actual or facsimile signature. 
 Section 20. Gender Neutral. 

Wherever used herein, a pronoun in the masculine gender shall be considered as including the feminine gender unless the context clearly
indicates otherwise. 
 *        *        *

 IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the date first above written. 

 

			
	AEGERION PHARMACEUTICALS, INC.
	
	 /S/

	By:	 	Christine A. Pellizzari
	Title:	 	 Executive Vice President,

General Counsel and Secretary

	
	EMPLOYEE
	
	 /S/

	 Martha J. Carter

21 Cedar Street
 Wenham, Massachusetts
09184

  
 12 

 EXHIBIT A 

CONFIDENTIALITY, ASSIGNMENT AND NONCOMPETITION AGREEMENT 
 [SEE ATTACHED] 

 Exhibit A 
 AEGERION PHARMACEUTICALS, INC. 
 Employee Confidentiality, Assignment and
Noncompetition Agreement 
 In consideration and as a condition of my employment or continued employment by Aegerion
Pharmaceuticals, Inc. (the “Company”), I agree as follows: 
 1. Employee Acknowledgements. I
acknowledge that I will be provided, and/or have been provided, with the Company’s trade secrets and/or valuable confidential business information, and have developed and/or will develop substantial relationships with prospective and existing
customers and clients of the Company, and, as a result, shall benefit from the Company’s good will. I also acknowledge that the Company has invested substantial resources in the development of its trade secrets, confidential business
information, client relationships and good will and in recruiting, hiring and training its professionals and staff. I further acknowledge that I have received and/or will receive substantial training from the Company. I hereby acknowledge and agree
that the Company has a legitimate interest in protecting its substantial investment in its development of trade secrets, confidential information, good will and a highly trained staff and that the covenants to which I agree to be bound herein are
necessary to protect such legitimate interests. 
 2. Proprietary Information. I agree that all information,
whether or not in writing, concerning the Company’s business, technology, business relationships or financial affairs which the Company has not released to the general public (collectively, “Proprietary Information”) is and will be
the exclusive property of the Company. By way of illustration, Proprietary Information may include information or material which has not been made generally available to the public, such as: (a) corporate information, including plans,
strategies, methods, policies, resolutions, negotiations or litigation; (b) marketing information, including strategies, methods, customer identities or other information about customers, prospect identities or other information about
prospects, or market analyses or projections; (c) financial information, including cost and performance data, debt arrangements, equity structure, investors and holdings, purchasing and sales data and price lists; and
(d) operational and technological information, including plans, specifications, manuals, forms, templates, software, designs, methods, procedures, formulas, discoveries, inventions, improvements, concepts and ideas; and
(e) personnel information, including personnel lists, reporting or organizational structure, resumes, personnel data, compensation structure, performance evaluations and termination arrangements or documents. Proprietary Information also
includes information received in confidence by the Company from its customers or suppliers or other third parties. 
 3.
Recognition of Company’s Rights. I will not, at any time, without the Company’s prior written permission, either during or after my employment, disclose any Proprietary Information to anyone outside of the Company, or use or
permit to be used any Proprietary Information for any purpose other than the performance of my duties as an employee of the Company. I will cooperate with the Company and use my best efforts to prevent the unauthorized disclosure of all Proprietary
Information. I will deliver to the Company all copies of Proprietary Information in my possession or control upon the earlier of a request by the Company or termination of my employment, 

 Exhibit A 

 

 4. Rights of Others. I understand that the Company is now and may
hereafter be subject to non-disclosure or confidentiality agreements with third persons which require the Company to protect or refrain from use of proprietary information. I agree to be bound by the terms of such agreements in the event I have
access to such proprietary information. 
 5. Commitment to Company; Avoidance of Conflict of Interest. While an
employee of the Company, I will devote my full-time efforts to the Company’s business and I will not engage in any other business activity that conflicts with my duties to the Company. I will advise the Chief Executive Officer of the Company at
such time as any activity of either the Company or another business presents me with a conflict of interest or the appearance of a conflict of interest as an employee of the Company, I will take whatever action is requested of me by the Company to
resolve any conflict or appearance of conflict which it finds to exist. 
 6. Developments. I will make full and
prompt disclosure to the Company of all inventions, discoveries, designs, developments, methods, modifications, improvements, processes, algorithms, databases, computer programs, formulae, techniques, trade secrets, graphics or images, and audio or
visual works and other works of authorship, whether or not patentable or copyrightable, that are created, made, conceived or reduced to practice by me (alone or jointly with others) or under my direction during the period of my employment
(collectively, the “Developments”), I acknowledge that all work performed by me is on a “work for hire” basis, and I hereby do assign and transfer and, to the extent any such assignment cannot be made at present, will assign and
transfer, to the Company and its successors and assigns all my right, title and interest in all Developments that: (a) relate to the business of the Company or any customer of the Company or any of the products or services being researched,
developed, manufactured or sold by the Company or which may be used with such products or services; or (b) result from tasks assigned to me by the Company; or (c) result and/or are developed during or after my employment from the use of
premises or personal properly (whether tangible or intangible) owned, leased or contracted for by the Company (collectively, “Company-Related Developments”), and all related patents, patent applications, trademarks and trademark
applications, copyrights and copyright applications, and other intellectual property rights in all countries and territories worldwide and under any international conventions (“Intellectual Property Rights”). 

To preclude any possible uncertainty, I have set forth on Exhibit A attached hereto a complete list of Developments that I have, alone or jointly
with others, conceived, developed or reduced to practice prior to the commencement of my employment with the Company that I consider to be my property or the property of third parties and that I wish to have excluded from the scope of this Agreement
(“Prior Inventions”). If disclosure of any such Prior Invention would cause me to violate any prior confidentiality agreement, I understand that I am not to list such Prior Inventions in Exhibit A but am only to disclose a cursory
name for each such invention, a listing of the party(ies) to whom it belongs and the fact that full disclosure as to such inventions has not been made for that reason. I have also listed on Exhibit A all patents and patent applications in
which I am named as an inventor, other than those which have been assigned to the Company (“Other Patent Rights”). If no such disclosure is attached, I represent that there are no Prior Inventions or Other Patent Rights. If, in the course
of my employment with the Company, I incorporate a Prior Invention into a Company product, process or machine or other work done for the Company, I hereby grant to the Company a nonexclusive, royalty-free, paid-up,

  
 2 

 Exhibit A 

 

 
irrevocable, worldwide license (with the full right to sublicense) to make, have made, modify, use, sell, offer for sale and import such Prior Invention, Notwithstanding the foregoing, I will not
incorporate, or permit to be incorporated, Prior Inventions in any Company-Related Development without the Company’s prior written consent. 
 This Agreement does not obligate me to assign to the Company any Development which, in the sole judgment of the Company, reasonably exercised, is developed entirely on my own time and does not relate to
the business efforts or research and development efforts in which, during the period of my employment, the Company actually is engaged or reasonably would be engaged, and does not result from the use of premises or equipment owned or leased by the
Company. However, I will also promptly disclose to the Company any such Developments for the purpose of determining whether they qualify for such exclusion. I understand that to the extent this Agreement is required to be construed in accordance
with the laws of any state which precludes a requirement in an employee agreement to assign certain classes of inventions made by an employee, this paragraph 5 will be interpreted not to apply to any invention which a court rules and/or the Company
agrees falls within such classes. I also hereby waive all claims to any moral rights or other special rights which I may have or accrue in any Company-Related Developments or Intellectual Property Rights. 

7. Documents and Other Materials. I will keep and maintain adequate and current records of: (a) all Proprietary
Information and Company-Related Developments developed by me during my employment; and (b) all documentation regarding any Intellectual Property Rights, which relate to such Proprietary Information and Company-Related Developments. Such records
will be available to and remain the sole property of the Company at all times. 
 All files, letters, notes, memoranda, reports, records, data,
sketches, drawings, notebooks, layouts, charts, quotations and proposals, specification sheets, or other written, photographic or other tangible material containing Proprietary Information, whether created by me or others, which come into my custody
or possession, are the exclusive property of the Company to be used by me only in the performance of my duties for the Company. Any property situated on the Company’s premises, owned or purchased by the Company, disseminated by the Company,
and/or used or created by me for business purposes in the course of my duties for the Company, including without limitation computers, email accounts, cell phone records and text messages, disks and other storage media, filing cabinets or other work
areas, is Company property and is subject to inspection by the Company at any time with or without notice. In the event of the termination of my employment for any reason, I will deliver to the Company all Company property, including, without
limitation, all Proprietary Information, all documents related to Company-Related Developments, all computers, keys, passwords, cell phones, entry cards, files, letters, notes, memoranda, reports, records, data, sketches, drawings, notebooks,
layouts, charts, quotations and proposals, specification sheets, or other written, photographic or other tangible material, and will not take or keep in my possession any Company property or any copies (electronic or hard-copy) of such property.

  
 3 

 Exhibit A 

 

 8. Enforcement of Intellectual Property Rights. I will cooperate fully
with the Company, both during and after my employment with the Company, with respect to the procurement, maintenance and enforcement of Intellectual Property Rights in Company-Related Developments. I will sign, both during and after the term of this
Agreement, all papers, including without limitation copyright applications, patent applications, declarations, oaths, assignments of priority rights, and powers of attorney, which the Company may deem necessary or desirable in order to protect its
rights and interests in any Company-Related Development. If the Company is unable, after reasonable effort, to secure my signature on any such papers, I hereby irrevocably designate and appoint each officer of the Company as my agent and
attorney-in-fact to execute any such papers on my behalf, and to take any and all actions as the Company may deem necessary or desirable in order to protect its rights and interests in any Company-Related Development. 

9. Non-Competition and Non-Solicitation. In order to protect the Company’s Proprietary Information and good will,
during my employment and for a period of twelve (12) months following the termination of my employment for any reason (the “Restricted Period”), I will not directly or indirectly, whether as owner, partner, shareholder, director,
manager, consultant, agent, employee, co-venturer or otherwise, engage, participate or invest in any business activity anywhere in the world that develops, manufactures or markets any products, or performs any services, that are competitive
(directly or indirectly) with the products or services of the Company, or products or services that the Company or its affiliates, has under development or that are the subject of active planning at any time during my employment; provided that this
shall not prohibit any possible investment in publicly traded stock of a company representing less than one percent of the stock of such company. In addition, during the Restricted Period, I will not, directly or indirectly, in any manner, other
than for the benefit of the Company, (a) call upon, solicit, divert, take away, accept or conduct any business from or with any of the customers or prospective customers of the Company or any of its suppliers, and/or (b) solicit, entice,
or attempt to persuade any other employee or consultant of the Company to leave the Company for any reason. I acknowledge and agree that if I violate any of the provisions of this paragraph 8, the running of the Restricted Period will be extended by
the time during which I engage in such violation(s). 
 10. Government Contracts. I acknowledge that the Company
may have from time to time agreements with other persons or with the United States Government or its agencies which impose obligations or restrictions on the Company regarding inventions made during the course of work under such agreements or
regarding the confidential nature of such work, I agree to comply with any such obligations or restrictions upon the direction of the Company. In addition to the rights assigned under paragraph 6, I also assign to the Company (or any of its
nominees) all rights which I have or acquired in any Developments, full title to which is required to be in the United States under any contract between the Company and the United States or any of its agencies. 

11. Prior Agreements. I hereby represent that, except as I have fully disclosed previously in writing to the Company, I am
not bound by the terms of any agreement with any previous employer or other party to refrain from using or disclosing any trade secret or confidential or proprietary information in the course of my employment with the Company or to refrain from
competing, directly or indirectly, with the business of such previous employer or 

  
 4 

 Exhibit A 

 

 
any other party. I further represent that my performance of all the terms of this Agreement as an employee of the Company does not and will not breach any agreement to keep in confidence
proprietary information, knowledge or data acquired by me in confidence or in trust prior to my employment with the Company. I will not disclose to the Company or induce the Company to use any confidential or proprietary information or material
belonging to any previous employer or others. 
 12. Remedies Upon Breach. 

(a) Equitable Relief. I understand that the restrictions contained in this Agreement are necessary for the protection of the
business and goodwill of the Company and I consider them to be reasonable for such purpose. Any breach of this Agreement is likely to cause the Company substantial and irrevocable damage and therefore, in the event of such breach, the Company, in
addition to such other remedies which may be available, will be entitled to seek specific performance and other injunctive relief, without the posting of a bond. 
 (b) Indemnification. If I violate this Agreement, in addition to all other remedies available to the Company at law, in equity, and under contract, I agree that I am obligated to pay all the
Company’s costs of enforcement of this Agreement, including attorneys’ fees and expenses. I also agree that I will indemnify and/or hold the Company harmless from and against any and all liabilities, losses, damages, claims or demands
whatsoever (including expenses, court costs and reasonable attorney’s fees) incurred by the Company (i) as a result of or by reason of the Company having to defend any claim arising from my use of proprietary or trade secret information of
a prior employer or my breach of a restrictive covenant with any prior employer, provided, that my obligations shall not arise unless and until a final judgment has been rendered in favor of such prior employer and (ii) from any damages
resulting from a final judgment of such claims. This indemnification shall include, but not be limited to, claims for infringement of patents, trademarks or copyrights, misappropriation of trade secrets or confidential information, and/or breach of
any restrictive covenants, and is without prejudice to any of Company’s other rights or remedies at law. 
 13. Use
of Voice, Image and Likeness. During the period of my employment, I give the Company permission to use any and all of my voice, image and likeness, with or without using my name, in connection with the products and/or services of the
Company, for the purposes of advertising and promoting such products and/or services and/or the Company, and/or for other purposes deemed appropriate by the Company in its reasonable discretion, except to the extent expressly prohibited by law.

 14. Publications and Public Statements. I will obtain the Company’s written approval before publishing or
submitting for publication any material that relates to my work at the Company and/or incorporates any Proprietary Information. 

15. No Employment Obligation. I understand that this Agreement does not create an obligation on the Company or any other
person to continue my employment. I acknowledge that, unless otherwise agreed in a formal written employment agreement signed on behalf of the Company by an authorized officer, my employment with the Company is at will and therefore may be
terminated by the Company or me at any time and for any reason, with or without cause. 

  
 5 

 Exhibit A 

 

 16. Survival and Assignment by the Company. I understand that my
obligations under this Agreement will continue in accordance with its express terms regardless of any changes in my title, position, duties, salary, compensation or benefits or other terms and conditions of employment. I further understand that my
obligations under this Agreement will continue following the termination of my employment regardless of the manner of such termination and will be binding upon my heirs, executors and administrators. The Company will have the right to assign this
Agreement to its affiliates, successors and assigns. I expressly consent to be bound by the provisions of this Agreement for the benefit of the Company or any parent, subsidiary or affiliate to whose employ I may be transferred without the necessity
that this Agreement be resigned at the time of such transfer, 
 17. Updating Information to the Company; Disclosure to
Future Employers. For twelve (12) months following termination of my employment, I will notify the Company of any change in my address and of each subsequent employment or business activity, including the name and address of my employer
or other post-Company employment plans and the nature of my activities. 
 18. Reimbursement. I hereby authorize
the Company at any time during or after the term of my employment to withhold from any amounts otherwise owed to me (including, but not limited to, salary, bonus, severance, commissions and expense reimbursements) to the fullest extent permitted by
applicable law: any and all amounts due to the Company from me, including, but not limited to, cash advances, draws, travel advances, overpayments made by the Company to me, amounts received by me due to the Company’s error, unpaid personal
credit card or phone charges or any other debt I owe to the Company for any reason, including amounts with respect to misuse or misappropriation of Company assets or breach of this Agreement. 

19. Severability. In case any provisions (or portions thereof) contained in this Agreement shall, for any reason, be held
invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect the other provisions of this Agreement, and this Agreement shall be construed as if such invalid, illegal or unenforceable provision
had never been contained herein, If, moreover, any one or more of the provisions contained in this Agreement shall for any reason be held to be excessively broad as to duration, geographical scope, activity or subject, it shall be construed by
limiting and reducing it, so as to be enforceable to the extent compatible with the applicable law as it shall then appear. 

20. Interpretation. This Agreement will be deemed to be made and entered into in the Commonwealth of Massachusetts, and
will in all respects be interpreted, enforced and governed under the laws of the Commonwealth of Massachusetts. I hereby agree to consent to personal jurisdiction of the state and federal courts situated within Suffolk County, Massachusetts for
purposes of enforcing this Agreement, and waive any objection that I might have to personal jurisdiction or venue in those courts. 

  
 6 

 Exhibit A 

 

 I UNDERSTAND THAT THIS AGREEMENT AFFECTS IMPORTANT RIGHTS. BY SIGNING BELOW, I CERTIFY THAT I HAVE
READ IT CAREFULLY AND AM SATISFIED THAT I UNDERSTAND IT COMPLETELY. 
 IN WITNESS WHEREOF, the undersigned has executed this
agreement as a sealed instrument as of the date set forth below. 
  

			
	Signed:	 	 /S/

		 	(Employee’s full name)

 Type or print
name: Martha A. Carter 
 Date: 3 February 2011 

  
 7 

 Exhibit A 

 

			
	 To:
	 	Aegerion Pharmaceuticals, Inc.,
		
	 From:
	 	Martha J. Carter
		
	 Date:
	 	3 February 2011
		
	 SUBJECT:
	 	Prior Inventions

 The following is a
complete list of all inventions or improvements that have been made or conceived or first reduced to practice by me alone or jointly with others prior to my engagement by the Company: 

 

			
	 x
	  	No inventions or improvements
		
	  ̈
	  	See below:
		
		  	  

		
		  	  

		
		  	  

		
	  ̈
	  	Additional sheets attached

 The following
is a list of all patents and patent applications in which I have been named as an inventor: 
  

			
	 x
	  	None
		
	  ̈
	  	See below:
		
		  	  

		
		  	  

		
		  	  

  
 8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00189-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00189-of-00352.parquet"}]]